chr22-23793695-C-T

Variant names:

• chr22-23793695-C-T
• rs34746244
• NM_003073.5:c.362+7C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BS1 BS2

The NM_003073.5(SMARCB1):​c.362+7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,613,610 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

• Frequency:
  • Genomes: 𝑓 0.0075 (13 hom., cov: 32)
  • Exomes 𝑓: 0.0010 (11 hom.)
• Consequence: SMARCB1 NM_003073.5 splice_region, intron
• Scores: Splicing: ADA: 0.00004147
• Clinical Significance: Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11
• Conservation: PhyloP100: -0.268
• Publications: 1 publications found

Genes affected

SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]

SMARCB1 Gene-Disease associations (from GenCC):

• Coffin-Siris syndrome

  Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
• intellectual disability, autosomal dominant 15

  Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
• rhabdoid tumor predisposition syndrome 1

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
• SMARCB1-related schwannomatosis

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
• familial multiple meningioma

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• familial rhabdoid tumor

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• schwannomatosis

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• complex neurodevelopmental disorder

  Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

ACMG classification

Our verdict: Benign. The variant received -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.87).
• BP6: Variant 22-23793695-C-T is Benign according to our data. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23793695-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 239483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BS1: Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0075 (1141/152146) while in subpopulation AFR AF = 0.0249 (1033/41504). AF 95% confidence interval is 0.0236. There are 13 homozygotes in GnomAd4. There are 573 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
• BS2: High AC in GnomAd4 at 1141 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
SMARCB1	NM_003073.5	c.362+7C>T		splice_region_variant, intron_variant	Intron 3 of 8	ENST00000644036.2	NP_003064.2
SMARCB1	NM_001362877.2	c.362+7C>T		splice_region_variant, intron_variant	Intron 3 of 8		NP_001349806.1
SMARCB1	NM_001317946.2	c.335+7C>T		splice_region_variant, intron_variant	Intron 3 of 8		NP_001304875.1
SMARCB1	NM_001007468.3	c.335+7C>T		splice_region_variant, intron_variant	Intron 3 of 8		NP_001007469.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
SMARCB1	ENST00000644036.2	c.362+7C>T		splice_region_variant, intron_variant	Intron 3 of 8		NM_003073.5	ENSP00000494049.2

Frequencies

GnomAD3 genomes AF: 0.00749 AC: 1139 AN: 152028 Hom.: 13 Cov.: 32

Gnomad AFR AF: 0.0249

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00334

Gnomad ASJ AF: 0.00837

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.000207

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.0127

Gnomad NFE AF: 0.000206

Gnomad OTH AF: 0.00478

GnomAD2 exomes AF: 0.00233 AC: 586 AN: 251450 AF XY: 0.00180

Gnomad AFR exome AF: 0.0252

Gnomad AMR exome AF: 0.00147

Gnomad ASJ exome AF: 0.00853

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.000202

Gnomad OTH exome AF: 0.00244

GnomAD4 exome AF: 0.00102 AC: 1490 AN: 1461464 Hom.: 11 Cov.: 32 AF XY: 0.000978 AC XY: 711 AN XY: 727054

African (AFR) AF: 0.0262 AC: 878 AN: 33470

American (AMR) AF: 0.00157 AC: 70 AN: 44710

Ashkenazi Jewish (ASJ) AF: 0.00857 AC: 224 AN: 26128

East Asian (EAS) AF: 0.00 AC: 0 AN: 39678

South Asian (SAS) AF: 0.0000580 AC: 5 AN: 86246

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53378

Middle Eastern (MID) AF: 0.00329 AC: 19 AN: 5768

European-Non Finnish (NFE) AF: 0.000144 AC: 160 AN: 1111716

Other (OTH) AF: 0.00222 AC: 134 AN: 60370

GnomAD4 genome AF: 0.00750 AC: 1141 AN: 152146 Hom.: 13 Cov.: 32 AF XY: 0.00771 AC XY: 573 AN XY: 74366

African (AFR) AF: 0.0249 AC: 1033 AN: 41504

American (AMR) AF: 0.00334 AC: 51 AN: 15282

Ashkenazi Jewish (ASJ) AF: 0.00837 AC: 29 AN: 3466

East Asian (EAS) AF: 0.00 AC: 0 AN: 5176

South Asian (SAS) AF: 0.000207 AC: 1 AN: 4820

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 10564

Middle Eastern (MID) AF: 0.0102 AC: 3 AN: 294

European-Non Finnish (NFE) AF: 0.000206 AC: 14 AN: 68014

Other (OTH) AF: 0.00473 AC: 10 AN: 2114

Alfa AF: 0.00452 Hom.: 8

Bravo AF: 0.00894

Asia WGS AF: 0.00173 AC: 6 AN: 3478

EpiCase AF: 0.000327

EpiControl AF: 0.000178

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:11

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:4

Nov 28, 2023

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Feb 04, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

May 25, 2016

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant summary: The SMARCB1 c.362+7C>T variant involves the alteration of a non-conserved intronic nucleotide. 5/5 splice tools predicting the variant not to have an impact on normal splicing. This variant was found in 319/121310 control chromosomes (including 1 homozygote), predominantly observed in the African subpopulation at a frequency of 0.0251251 (261/10388). This frequency greatly exceeds the estimated maximal expected allele frequency of a pathogenic SMARCB1 variant (0.0000001), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. Taken together, this variant is classified as Benign. -

not specified Benign:2

Aug 07, 2017

GeneDx

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 23, 2021

Genetic Services Laboratory, University of Chicago

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Rhabdoid tumor predisposition syndrome 1 Benign:2

Jul 07, 2023

KCCC/NGS Laboratory, Kuwait Cancer Control Center

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

SMARCB1-related schwannomatosis Benign:2

Feb 01, 2025

KCCC/NGS Laboratory, Kuwait Cancer Control Center

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Coffin-Siris syndrome Benign:1

Jun 13, 2023

Department of Pathology and Laboratory Medicine, Sinai Health System

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.87
CADD	Benign	0.57
DANN	Benign	0.44
PhyloP100		-0.27
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Benign	0.000041
dbscSNV1_RF	Benign	0.0
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs34746244; hg19: chr22-24135882;